Search
for
Sort by
Research 811–840 of 1000+
- Janus kinase inhibitors for alopecia areata: A narrative review
- Circulating MicroRNA Signatures in Severe Alopecia Areata: Diagnostic Discrimination, Pathway Analysis, and Therapeutic Implications
- Alopecia areata and ritlecitinib: Unravelling response trajectories
- Topical metformin as a novel therapy for alopecia areata due to its immunologic effects
- ORAL TOFACITINIB IN MODERATE AND SEVERE ALOPECIA AREATA: CASE SERIES OF 14 PATIENTS
- COMPARATIVE STUDY BETWEEN INTRALESIONAL INJECTION OF PLATELET RICH PLASMA AND INTRA LESIONAL TRIAMCINOLONE FOR THE TREATMENT OF ALOPECIA AREATA
- Trichoscopic findings in children and adults with alopecia areata: A comparative study
- Comparative efficacy of topical calcipotriol and tacrolimus in alopecia areata: A prospective trial
- Comparative efficacy of topical calcipotriol and tacrolimus in alopecia areata: A prospective trial
- Prediction of the Mechanism of Shaoyao Gancao Decoction in the Treatment of Alopecia Areata by Network Pharmacology and Its Preliminary Verification Study
- Classification and Scoring of Androgenetic Alopecia (Male and Female Pattern)
- The 100 most cited articles in androgenetic alopecia: A bibliometric analysis
- Immunology of alopecia areata
- Unsuccessful Treatment of Alopecia Areata with Simvastatin/Ezetimibe: Experience in 12 Patients
- Carotid Intima Media Thickness Measurement in Alopecia Areata Patients
- Comparison of Clinical Efficacy and Trichoscopic Changes in Alopecia Areata of the Scalp following Treatment with Intralesional Triamcinolone Acetonide and Autologous Platelet-Rich Plasma
- Role of Cytotoxic T Cells in Chronic Alopecia Areata
- Utility of dermoscopy in alopecia areata
- Alopecia areata: What’s new in the epidemiology, comorbidities, and pathogenesis?
- Baricitinib for the Treatment of Alopecia Areata
- A review of Janus kinase inhibitor use in scarring alopecia
- More is not always better in hair growth factors. epidermal growth factor: hair growth factor involved in alopecia areata pathogenesis
- Alopecia and hair repigmentation associated with anti-programmed death-ligand 1 (PD-L1) immunotherapy
- Improvement in Patient‐Reported Emotional Symptoms and Activity Limitations due to Hair Loss in Patients With Alopecia Areata Treated With Ritlecitinib: Additional Analyses From ALLEGRO ‐2b/3
- Serum levels of interleukin-1 (IL-1α, IL-1β) in patients with alopecia areata
- Modified platelet rich plasma therapy for alopecia totalis
- Systemic Tofacitinib Treatment in Pediatric Patients with Resistant Alopecia Areata
- Clinical Trial Eligibility in Real‐World Alopecia Areata Patients Treated With Baricitinib
- Evaluation of the Relationship between Alopecia Areata and Viral Antigen Exposure
- Duration of current alopecia areata episode predicts the effectiveness of baricitinib in Japanese patients with alopecia areata: a single-center retrospective study